GlaxoSmithKline (Multiple Sclerosis Drug) Overview
- Year Founded
-
1935
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
GlaxoSmithKline (Multiple Sclerosis Drug) General Information
Description
Developer of medicine. The company develops drugs for the treatment of multiple sclerosis disease and cancer in the United Kingdom.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
GlaxoSmithKline (Multiple Sclerosis Drug) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GlaxoSmithKline (Multiple Sclerosis Drug) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|